Study to Evaluate the Safety and Efficacy of HLBLS-200 in Patients Requiring Hemostatic Technique

NCT03957356 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

HLB Cell Co., Ltd.